News

Published on 5 May 2024 on Simply Wall St. via Yahoo Finance

Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been...


Article preview image

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) just released its quarterly report and things are looking bullish. It was a solid earnings report, with revenues and statutory earnings per share (EPS) both coming in strong. Revenues were 10% higher than the analysts had forecast, at US$413m, while EPS were US$0.37 beating analyst models by 957%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Check out our latest analysis for Sarepta Therapeutics

earnings-and-revenue-growthearnings-and-revenue-growth

NASDAQ.SRPT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Quant Ratings Updated on 85 Stocks

As I expected, the stock market was relatively quiet as folks headed out early for the holiday. T...

InvestorPlace 3 Dec 2024

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap...

These eight mid-cap stocks were the best performers in the last week. Are they in your portfolio?...

Benzinga 1 Dec 2024

Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers...

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?...

Benzinga 1 Dec 2024

Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin...

Shares of Century Therapeutics Inc IPSC zoomed by 20.74% to $1.63 per share on Wednesday, which i...

Benzinga 27 Nov 2024

Biotech ETF (XBI) ended a diagonal – Looking for buying dips

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the biotechnology segment o...

The Forex Market 27 Nov 2024

Sarepta Therapeutics, Inc. (SRPT): Among 12 High Growth Large Cap Stocks to Buy...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 15 Nov 2024

Sarepta Therapeutics, Inc. (SRPT): An Unstoppable Stock That Could Make You...

We recently compiled a list of the 8 Unstoppable Stocks That Could Make You Richer. In this artic...

Insider Monkey · via Yahoo Finance 27 Oct 2024

Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Biotech Stock According...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 16 Oct 2024

Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to...

We recently published a list of the 7 Best Revenue Growth Stocks to Buy According to Analysts. In...

Insider Monkey · via Yahoo Finance 2 Oct 2024

Sarepta Therapeutics, Inc. (SRPT): This Biotech Stock Should Be On Your Radar

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. ...

Insider Monkey · via Yahoo Finance 22 Sep 2024